Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 8 of 8 for “"Genetically engineered T cells"”.
-
ASYMMETRIC CELL DIVISION AS A MECHANISM OF FATE INDUCTION IN GENETICALLY ENGINEERED T CELLS
… and chimeric autoantibody receptor (CAAR) T cells are novel cellular immunotherapy strategies that have recently entered clinical practice for the treatment of malignancies and autoimmune diseases. Early expansion and long-term persistence of these genetically engineered T cells predict …
-
Modulation of CAR-LCK engagement to augment the anti-tumor function of genetically engineered T-cells
… with chimeric antigen receptor (CAR)-T cells has dramatically altered the landscape of cancer therapy. However, despite impressive clinical responses and high rates of complete remission observed in B-cell acute lymphoblastic leukemia, lymphomas and multiple myeloma, there is still a …
-
Cd56-Specific T Cells: Using Genetically Engineered T Cells to Redirect Specificity to A T Cell Expressed Antigen
… for applying CARs to new targets. Using T cells to target a T cell expressed antigen, such as CD56, seems counterintuitive in that the T cells would be susceptible to self-targeting a.k.a. fratricide. However, we expand CD56-specific CAR+ T cells that co-express the CD56 antigen. Since …
-
DEVELOPING OF CAR-B CELL IMMUNOTHERAPY TO TARGET MESOTHELIN IN OVARIAN CANCER
… (CAR-T) therapy is an immunotherapy that use genetically engineered T cells expressing CARs that can recognize tumor surface antigens to destroy tumor cells. This immunotherapy exhibits promising clinical outcomes for treating patients with hematological cancers. Currently, there are five …
-
MECHANISTIC IMPACT OF OLIGOMER POISONING BY DOMINANT-NEGATIVE CARD11 VARIANTS
… CARD11 signaling cycle to branched pathways in genetically engineered T cells expressing LOF CARD11 variants in both the absence and presence of wild-type CARD11. We identified the mechanistic basis for dominant-negative CARD11 variants and provide insights into how some LOF alleles may cause …
-
Identification and functional characterization of genomic features associated with T-cell-specific gene expression
… of transcriptional regulation is important in T cells, given the growing impact of genetically engineered T cells in gene therapy. Although many transcription factors (TFs) central to T-cell identity have been extensively studied, far less is known about the broader set of genomic features that …
-
Developing an ‘Off-the-Shelf’ Engineered γδ T Cell Therapy for Multiple Myeloma
… disease. In recent years, adoptive transfer of genetically engineered T cells, such as chimeric antigen receptor (CAR)-T cell therapy has realized remarkable clinical responses in hematologic malignancies. The conventional CAR-T cell platform confers tumour antigen specificity of conventional T …
-
Ανάπτυξη και αξιολόγηση πειραματικού συστήματος κυτταρικής ανοσοθεραπείας του καρκίνου των ωοθηκών
… and characterization of rare antigen-specific T cells from each patient thus limiting its broad application. However, large amounts of tumor-reactive T cells with redirected specificity toward tumor associated antigens (TAA) can be generated following their genetic engineering with: A. …